NovoCure (NVCR) Return on Capital Employed Growth (1y) (2016 - 2026)
NovoCure (NVCR) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 125.00 |
| 10 | NovoCure | 2.01 Bn | 1.57 Bn | 142.48 Mn | 767.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 767.00 |
| Mar 31, 2026 | 158.00 |
| Dec 31, 2025 | 1,800.00 |
| Sep 30, 2025 | -53.00 |
| Jun 30, 2025 | -1,617.00 |
| Mar 31, 2025 | -1,127.00 |
| Dec 31, 2024 | -1,182.00 |
| Sep 30, 2024 | -1,045.00 |
| Jun 30, 2024 | 19.00 |
| Mar 31, 2024 | -759.00 |
| Dec 31, 2023 | -1,534.00 |
| Sep 30, 2023 | -1,571.00 |
| Jun 30, 2023 | -1,346.00 |
| Mar 31, 2023 | -997.00 |
| Dec 31, 2022 | -425.00 |
| Sep 30, 2022 | -591.00 |
| Jun 30, 2022 | -680.00 |
| Mar 31, 2022 | -798.00 |
| Dec 31, 2021 | -933.00 |
| Sep 30, 2021 | -570.00 |